Orbimed Advisors - NEXTCURE INC ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of NEXTCURE INC
ValueSharesWeighting
Q3 2023$3,497,207
-28.3%
2,711,0130.0%0.07%
-15.9%
Q2 2023$4,879,823
+21.6%
2,711,0130.0%0.09%
+11.4%
Q1 2023$4,012,299
+5.0%
2,711,0130.0%0.08%
+8.2%
Q4 2022$3,822,528
-48.7%
2,711,0130.0%0.07%
-47.1%
Q3 2022$7,455,000
-41.5%
2,711,0130.0%0.14%
-40.3%
Q2 2022$12,742,000
-3.3%
2,711,0130.0%0.23%
+7.9%
Q1 2022$13,176,000
-19.0%
2,711,0130.0%0.21%
+2.4%
Q4 2021$16,266,000
-11.0%
2,711,0130.0%0.21%
+4.0%
Q3 2021$18,272,000
-16.1%
2,711,0130.0%0.20%
-8.6%
Q2 2021$21,769,000
-19.8%
2,711,0130.0%0.22%
-13.4%
Q1 2021$27,137,000
-8.2%
2,711,0130.0%0.25%
-1.9%
Q4 2020$29,550,000
+23.9%
2,711,0130.0%0.26%
-13.7%
Q3 2020$23,857,000
-59.0%
2,711,0130.0%0.30%
-63.3%
Q2 2020$58,124,000
-42.2%
2,711,0130.0%0.82%
-51.6%
Q1 2020$100,497,000
-34.2%
2,711,0130.0%1.69%
-22.5%
Q4 2019$152,711,000
+82.6%
2,711,0130.0%2.18%
+37.4%
Q3 2019$83,635,000
+105.9%
2,711,0130.0%1.59%
+152.3%
Q2 2019$40,611,0002,711,0130.63%
Other shareholders
NEXTCURE INC shareholders Q4 2023
NameSharesValueWeighting ↓
K2 PRINCIPAL FUND, L.P. 1,581,311$4,186,0000.48%
Sofinnova Investments, Inc. 2,671,856$7,348,0000.43%
Long Focus Capital Management, LLC 556,105$1,529,0000.15%
DAFNA Capital Management LLC 187,696$516,0000.14%
Orbimed Advisors 2,711,013$7,455,0000.14%
Sio Capital Management, LLC 130,000$358,0000.11%
FNY Investment Advisers, LLC 48,000$132,0000.09%
Privium Fund Management (UK) Ltd 24,400$67,0000.08%
Minerva Advisors LLC 31,713$87,0000.07%
Krensavage Asset Management, LLC 31,298$86,0000.03%
View complete list of NEXTCURE INC shareholders